切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2009, Vol. 05 ›› Issue (05) : 473 -476. doi: 10.3877/cma.j.issn.1673-5250.2009.05.104

论著

华蟾素对子宫内膜癌HHUA细胞芳香化酶表达的影响和意义
王绍光, 姜学强   
  1. 264000 山东青岛,青岛大学医学院附属烟台毓璜顶医院妇产科
  • 出版日期:2009-10-01

Effects and Significance of Cinobufagin on the Expression of Aromatase in the Endometrial Carcinoma HHUA Cells

Shao-guang WANG, Xue-qiang JIANG   

  1. Department of Obstetrics and Gynecology, Yantai Yuhuangding Hospital, Medical College of Qingdao University, Yantai 264000, China
  • Published:2009-10-01
  • Supported by:
    * Project No. 2005126, supported by the Yantai Science and Technology Development Plan
引用本文:

王绍光, 姜学强. 华蟾素对子宫内膜癌HHUA细胞芳香化酶表达的影响和意义[J]. 中华妇幼临床医学杂志(电子版), 2009, 05(05): 473-476.

Shao-guang WANG, Xue-qiang JIANG. Effects and Significance of Cinobufagin on the Expression of Aromatase in the Endometrial Carcinoma HHUA Cells[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2009, 05(05): 473-476.

目的

探讨华蟾素(cinobufagin)对体外培养子宫内膜癌HHUA细胞芳香化酶和雌二醇(estradiol,E2)表达的影响和意义。

方法

30例原代培养的正常子宫内膜组织和30例子宫内膜癌HHUA细胞分别取自2007年至2008年因功能性子宫出血(功血)而在本院诊刮和因子宫内膜癌在本院手术治疗患者。其组织学检查分别确诊为增生期内膜和子宫内膜癌HHUA细胞,体外(in vitro)培养正常子宫内膜细胞(A组,n=30)和子宫内膜癌HHUA细胞。再将30例子宫内膜癌患者的子宫内膜癌HHUA细胞分成两部分,一部分纳入子宫内膜癌HHUA细胞组(B组,n=30),一部分用华蟾素干预后,纳入子宫内膜癌HHUA细胞华蟾素干预组(C组,n=30),应用RT–PCR检测芳香化酶表达,发光免疫法检测雌二醇表达,流式细胞仪检测细胞凋亡。

结果

正常子宫内膜细胞(A组)不表达芳香化酶mRNA(aromatase mRNA),不合成雌二醇,细胞凋亡率为(8.02±0.93)%;子宫内膜癌HHUA细胞(B组)表达芳香化酶mRNA,可合成雌二醇,细胞凋亡率为(1.08±0.21)%,低于正常子宫内膜细胞 (P<0.05)。华蟾素干预(C组)后,子宫内膜癌HHUA细胞芳香化酶mRNA的表达和雌二醇的合成均下降,细胞凋亡率为(27.14±4.12)%,高于B组(P<0.05)。

结论

子宫内膜癌HHUA细胞可利用芳香化酶合成内源性雌二醇,华蟾素可抑制子宫内膜癌HHUA细胞芳香化酶mRNA的表达和雌二醇的合成,抑制癌细胞增殖。

Objective

To investigate the effects and significance of cinobufagin on the expression of aromatase and estrodiol(E2) in the endometrial carcinoma HHUA cells cultured in vitro.

Methods

The primary culture of normal endometrial cells were taken from patients who did diagnostic curettage for functional uterine bleeding(FUB) in our hospital from 2007 to 2008, and the pathology revealed proliferative endometrial cells as the normal endometrial cells(group A, n=30). The pathology revealed as the endometrial carcinoma HHUA cells which were divided into two parts. Half of them were classified into endometrial carcinoma HHUA cells group (group B, n=30), and half were cultured in vitro, after the action of cinobufagin into endometrial carcinoma HHUA cells action by cinobufagin group (group C, n=30). The expression of aromatase was measured by RT-PCR, the expression of estrodiol was determined by immunofluorometry, and the cellular apoptosis was tested by flow cytometry.

Results

Group A neither expressed aromatase mRNA nor synthesize estrodiol, the cellular apoptotic rate was (8.02±0.93)%. Group B could both express aromatase mRNA and synthesize estradiol by the aromatase, and the cellular apoptotic rate was (1.08±0.21)%, which was lower than that of group A(P<0.05). After the action of cinobufagin(group C), aromatase mRNA expression and estrodiol synthesis of endometrial carcinoma HHUA cells were significantly down-regulated, the cellular apoptotic rate was (27.14±4.12)%, which was lower than that of group B (P<0.05).

Conclusion

The endometrial carcinoma HHUA cells can synthesize endogenous estradiol by aromatase. The cinobufagin may inhibit the expression of aromatase mRNA and the synthesis of the estrodiol, resulting the inhibition of endometrial carcinoma cells' proliferation.

图1 子宫内膜癌HHUA细胞芳香化酶mRNA电泳光带
1 Krasner C. Aromatase inhibitors in gynecologic cancers. J Steroid Biochem Mol Biol, 2007, 106(1–5): 76–80.
2 Bulun SE, Chen D, Lu M, et al. Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol, 2007, 106(1– 5): 81–96.
3 Gurates B, Sebstian S, Yang S, et al. WT1 and DAX–1inhibit aromatase p450 expression in human endometrial and endometriotic stromal cell. J Clin Endocrinol Metab, 2007, 87(9): 4369–4367.
4 Gligorov J, Pritchard K, Goss P. Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis. Breast, 2007, 16(3): 1–9.
5 Utsunomiya H, Yaegashi N. Biological roles of estrogen and progesterone in human endometrial carcinoma–new developments in potential endocrine therapy for endometrial cancer. Endocr J, 2007, 54(5): 667–679.
6 Olson SH, Bandera EV, Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: A HuGE review. Am J Epidemiol, 2007, 165(3): 235–245.
7 Khadzhiolov N, Ivanov S. Expression of oncogene proteins Bag–1, p53, and bcl–2 in endometrium adenocarcinoma with different rate of differentiation. Akush Ginekol, 2004, 43(2): 35–36.
[1] 王青青, 耿翠芝, 苏晓雨, 彭玉晓, 秦明祎, 刘风侠. 乳腺癌芳香化酶抑制剂相关肌肉骨骼不良反应的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 243-249.
[2] 李康, 冀亮, 赵维, 林乐岷. 自噬在乳腺癌生物学进展中的双重作用[J]. 中华乳腺病杂志(电子版), 2023, 17(04): 195-202.
[3] 孔莹莹, 谢璐涛, 卢晓驰, 徐杰丰, 周光居, 张茂. 丁酸钠对猪心脏骤停复苏后心脑损伤的保护作用及机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 355-362.
[4] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[5] 刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[6] 刘硕儒, 王功炜, 张斌, 李书豪, 胡成. 新型溶瘤病毒M1激活内质网应激致前列腺癌细胞凋亡的机制[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 388-393.
[7] 邵浩仁, 郭佳. 铁死亡的分子机制及其在前列腺癌治疗中的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 294-298.
[8] 邓春文, 陈嵩, 钟裴, 闵师强, 万健. LncRNA CRNDE通过miR-181a-5p/SOX6轴调节脂多糖诱导人肺泡上皮细胞的炎症反应和细胞凋亡[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 129-136.
[9] 余慧, 王静, 杜丹, 杨帆. 下调miR-301a-3p抑制人卵巢颗粒KGN细胞增殖和诱导凋亡的机制研究[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 137-143.
[10] 樱峰, 王静, 刘雪清, 李潇. 水通道蛋白1对人角膜内皮细胞增殖、迁移及凋亡影响的实验研究[J]. 中华眼科医学杂志(电子版), 2023, 13(03): 146-151.
[11] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[12] 邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
[13] 张敏洁, 张小杉, 段莎莎, 施依璐, 赵捷, 白天昊, 王雅晳. 氢气治疗心肌缺血再灌注损伤的作用机制及展望[J]. 中华临床医师杂志(电子版), 2023, 17(06): 744-748.
[14] 郭如烨, 孟黎明, 陈楠, 宋玉莹, 尹海燕, 郭岩. Apelin/APJ系统对帕金森病模型的神经保护作用及机制研究进展[J]. 中华诊断学电子杂志, 2023, 11(04): 276-282.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要